News articles posted within the last two years are linked below for reference

Tree pollen season is here!

The southeastern Wisconsin tree pollen season officially started on March 22 - we've been a bit busy adapting to the challenges of a global pandemic on allergy practices in particular, and life in general! It's been a bit brisk, with the maximum count thus far of 719 on April 7. By comparison, last year, we didn't hit the 700 mark until April 17, and our 10-year average doesn't reach 700 until May 1. But the...

Posted on April 10, 2020 Read more...
Albuterol inhaler shortage during COVID-19

Patients with asthma or chronic obstructive pulmonary disease (COPD) may see delays in albuterol inhaler availability from their pharmacy due to the COVID-19 outbreak. The inhalers are being used in emergency rooms to treat respiratory distress from coronavirus infection. This increased demand is resulting in strain on manufacturers to keep up with production. While albuterol is also available through a nebulizer, emergency room physicians are concerned that using nebulizers in busy emergency rooms could result...

Posted on March 25, 2020 Read more...
An update on COVID-19

This article contains information that has changed since publication. Please visit our coronavirus page for updated information about Allergy, Asthma & Sinus Center COVID-19 policies. People with respiratory diseases such as asthma and COPD are at greater risk of complications from viral infections such as influenza and COVID-19. Understandably, the recent outbreak of COVID-19 has caused great concern among both health care professionals and patients, so we think it is important to make...

Posted on March 12, 2020 Read more...
Pollen season is coming!

If you had some sneezing and itchy eyes on Sunday, March 8, while out for a walk in the warm breeze, that was probably due to tree pollen, but not from our trees. When we have strong, warm winds out of the south, the jet stream brings pollen from trees already pollinating 500 or more miles south of us. But since the pollen isn't coming from our trees here in southeastern Wisconsin, as soon as...

Posted on March 9, 2020 Read more...
New research in chronic cough

One of the things we are particularly proud of is the ability to bring exciting new treatments under development to our patients and our community. An especially exciting area of research is chronic cough, which is a devastating condition that is a constant source of irritation and distraction for many people. Patients with chronic cough often cough 30-60 times an hour while awake, and some people even continue to cough in their sleep. The coughing...

Posted on March 3, 2020 Read more...
Palforzia: A treatment for peanut allergy

The FDA approved a treatment option for food allergy for the first time yesterday. Named Palforzia, it is for the treatment of peanut allergy. The principle is the same as with desensitization for other types of allergies. Starting with extremely low doses that the patient can tolerate, this oral medication is given in gradually increasing amounts over several months under an allergist’s supervision. As a result, the patient’s immune system learns not to react so...

Posted on February 1, 2020 Read more...
BE YOUR BEST FOR 2020!

The start of a new year is a great time to make resolutions to be healthy. But in addition to the common resolutions about diet and exercise, people who suffer from allergies and related conditions should resolve to take control of their allergies, and not let their allergies control their lives. See the detailed explanations on our Services page for more information on how AASC can help you meet your new year's resolution if...

Posted on January 15, 2020 Read more...
Dr. Steven attends the World Allergy Congress

The main reason Dr. Steven attends World Allergy Organization meetings when he can is that allergy is not practiced the same everywhere. The information presented at these international meetings is often different from, and complements, information available at US meetings. This year's Congress in Lyon, France, was no different. A great deal of work has been done worldwide in climate change and pollution. Regardless of the cause of climate change, pollen counts have been increasing...

Posted on December 30, 2019 Read more...
Dr. Steven presents in the Philippines

Dr. Steven traveled to Manila, Philippines earlier this month to present a lecture on Atopic Dermatitis to the first Skin Allergy Symposium of the Philippine Society of Allergy, Asthma & Immunology. Dr. Steven was chosen by the president of the American College of Allergy, Asthma & Immunology to present on the organization's behalf. The main thrust of the presentation was how to start with simple treatments that people can do at home and determine how...

Posted on June 13, 2019 Read more...
Dr. Steven visits Capitol Hill

For the third year in a row, Dr. Steven traveled to Washington DC last week to participate in Asthma Action Day on Capitol Hill. This patient advocacy event sponsored by the Allergy & Asthma Network starts with patient testimonials. This year, two families told their stories about the complications they endured during the long prior authorization process for lifesaving, but expensive treatments for their severe asthma. Dr. Steven was then assigned a busy agenda, meeting...

Posted on May 15, 2019 Read more...
Health Disparities and World Health Day

In support of World Health Day this past weekend, the Allergy, Asthma & Sinus Center would like to remind everyone that the important health disparities that the World Health Organization wants to address are just as important here in southeastern Wisconsin as they are across the world. We opened our north side satellite in 2016 and were surprised at how many treatment opportunities hadn't even been offered to patients just a few miles away on...

Posted on April 10, 2019 Read more...
Symjepi: A new option for injectable epinephrine

Sandoz Pharmaceuticals announced the introduction of Symjepi, a prefilled epinephrine syringe for the emergency treatment of severe allergic reactions. The Symjepi device is the fifth epinephrine injector on the market, joining EpiPen, the Epi-Pen authorized generic, Adrenaclick and Auvi-Q. Unlike the others, Symjepi is a manual syringe, rather than an autoinjector. While the first impression might be that an automatic injector would be better than having to inject epinephrine manually into the thigh, one study...

Posted on March 18, 2019 Read more...
Wixela: Generic version of Advair now approved

Mylan Pharmaceuticals announced that the FDA approved their new Wixela inhalers (the generic versions of Advair). The wholesale cost of Wixela is less than half the cost of Advair, so we will hopefully see some of the price relief we have long needed in the treatment of asthma! If you are looking for a less expensive option, we recommend first talking with your allergist about whether switching might be appropriate for you. Next, you will...

Posted on March 4, 2019 Read more...
FDA approves Primatene Mist

The FDA approved Primatene Mist last week for over-the-counter (OTC) status. It was taken off the market in 2011 because of its CFC propellants, which have been shown to damage the ozone layer. It is now being reintroduced with an ozone-safe HFA propellant, the same one used in all prescription metered-dose inhalers for asthma and COPD. Dr. Steven shares the concerns about this development that have been expressed by the President of the ACAAI,

Posted on November 12, 2018 Read more...
FDA alerts patients with EpiPens

From the FDA: FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may block access to the auto-injector and prevent the ability to easily access the product. In a letter to health care professionals from Pfizer, the manufacturer of the Mylan EpiPen, the label sticker on the auto-injector unit may have been improperly applied, causing...

Posted on November 7, 2018 Read more...
Publication: Shared decision making for the allergist

We are proud to announce the online publication of the review article “Shared decision making for the allergist” in the Annals of Allergy, Asthma & Immunology, October 2018. Dr. Steven was the second author for this publication in recognition of his contribution of the general design of the user interface. A longtime strong believer in the need for patients to understand all of their treatment options for a given condition,...

Posted on November 1, 2018 Read more...
Dupixent: New treatment for asthma

Last week, the FDA announced the approval of a new medication for asthma, Dupixent. This is the fifth monoclonal antibody approved for asthma, utilizing a fourth mechanism of action. Unlike steroids, which are known to alter at least 800 different inflammatory chemicals in the body, monoclonal antibodies latch on to a single protein. The trick is to figure out which proteins are most important in asthmatic inflammation in general, and which one or ones might...

Posted on October 23, 2018 Read more...
Peanut Allergy Alert: Ice Cream Recall

From the FDA: Kemps of St. Paul, Minn., is voluntarily recalling Sweet Me Creamery Brookie Dough ice cream, individual pints and pint four-packs, because it may contain an undeclared peanut allergen. Individuals who have an allergy or severe sensitivity to peanuts run the risk of a serious or life-threatening allergic reaction if they consume these products. The recalled products were initially distributed by Kemps to retailers and retailer distribution centers in Illinois, Minnesota, North Dakota,...

Posted on October 22, 2018 Read more...
National Penicillin Allergy Day

September 28, 2018 Milwaukee, WI - Allergy, Asthma & Sinus Center (AASC) announced today its participation in the second annual National Penicillin Allergy Day, a national awareness day to help spread the word and educate the healthcare community and the broader U.S. public on penicillin allergy and the critical importance of testing for this allergy. This date has maintained its significance as the day Alexander Fleming discovered penicillin, the...

Posted on September 28, 2018 Read more...
Are you able to enjoy peanuts?

Today is National Peanut Day, a celebration of the importance of peanut in our diet, culture and economy. Dr. George Washington Carver published his research on 105 ways to prepare peanut for human consumption in 1916. But for an increasing number of people, the thought of hidden peanut in the diet is a constant source of anxiety and fright. If you or a loved one is affected by peanut allergy, it...

Posted on September 13, 2018 Read more...